Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivastigmine as a Treatment for Methamphetamine Dependence

NCT01073319 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT01073319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01073319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivastigmine as a Treatment for Methamphetamine Dependence
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2009
Completion date
July 31, 2010
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse, methamphetamine dependence, substance abuse